Camelliaside A

CAS: 135095-52-2

Ref. 3D-OC33270

Informação sobre produto

• Nome: Camelliaside A
• Sinónimos: Kaempferol-3-O-[2-O-b-D-galactose-6-O-a-L-rhamnose]-b-D-glucoside, Kaempferol 3-O-(2-O-galactopyranosyl-6-O-rhamnopyranosyl)glucopyranoside, k-Gal-rha-glu, 4H-1-Benzopyran-4-one, 3-((O-6-deoxy-alpha-L-mannopyranosyl-(1-6)-O-(beta-D-galactopyranosyl-(1-2))-beta-D-glucopyranosyl)oxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->2)]-alpha-D-glucopyranoside

Descrição

Camelliaside A is a saponin that has been shown to have a variety of physiological activities. It has been found to inhibit the growth of tumour cells and induce apoptosis in vitro. Camelliaside A also has an inhibitory effect on the enzymatic reaction, which may be due to its ability to inhibit the activity of phospholipase C (PLC). This compound has also been demonstrated to have antitumour activity, as well as inhibiting the production of pro-inflammatory cytokines such as IL-6 and IL-8. Camelliaside A is able to reduce blood pressure and fat cell size in vivo.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 756.66 g/mol
• Fórmula: C₃₃H₄₀O₂₀
• Pureza: Min. 95%
• Cor/forma: Solid